XML 84 R23.htm IDEA: XBRL DOCUMENT v2.4.1.9
Net Earnings (Loss) Per Common Share
 3 Months Ended
Mar. 31, 2015
Earnings Per Share [Abstract]  
Net Earnings (Loss) Per Common Share
Net Earnings (Loss) Per Common Share

The following table sets forth the computation of basic and diluted net earnings (loss) per common share for the periods indicated. 
(In thousands except per share data)
For the Three Months Ended March 31,
 
2015
 
2014
Basic
 
 
 
Average common shares outstanding
32,125

 
32,013

 
 
 
 
Net loss from continuing operations
$
(7,514
)
 
$
(18,895
)
Net earnings from discontinued operations
$
260

 
$
919

Net loss
$
(7,254
)
 
$
(17,976
)
 
 
 
 
Net loss per common share from continuing operations
$
(0.23
)
 
$
(0.59
)
Net earnings per common share from discontinued operations
$
0.01

 
$
0.03

Net loss per common share
$
(0.23
)
 
$
(0.56
)
 
 
 
 
Diluted
 
 
 
Average common shares outstanding
32,125

 
32,013

Stock options and awards
264

 
288

Average common shares assuming dilution
32,389

 
32,301

 
 
 
 
Net loss from continuing operations
$
(7,514
)
 
$
(18,895
)
Net earnings from discontinued operations
$
260

 
$
919

Net loss
$
(7,254
)
 
$
(17,976
)
 
 
 
 
Net loss per common share from continuing operations *
$
(0.23
)
 
$
(0.59
)
Net earnings per common share from discontinued operations
$
0.01

 
$
0.03

Net loss per common share *
$
(0.23
)
 
$
(0.56
)


* Net loss per common share assuming dilution calculated utilizing weighted average shares outstanding-basic for the periods in which there was a net loss.

At March 31, 2015, 2,771,375 shares associated with stock options were excluded from the average common shares assuming dilution for the three months ended March 31, 2015 as they were anti-dilutive. At March 31, 2015, the majority of the anti-dilutive shares were granted at an exercise price of $41.87, which was higher than the average fair market value prices of $17.32 for the three months ended March 31, 2015. At March 31, 2014, 2,525,703 shares associated with stock options were excluded from the average common shares assuming dilution for the three months ended March 31, 2014 as they were anti-dilutive. At March 31, 2014, the majority of the anti-dilutive shares were granted at an exercise price of $41.87, which was higher than the average fair market value prices of $20.57 for the three months ended March 31, 2014. For the three months ended March 31, 2015 and March 31, 2014, there were no shares necessary to settle a conversion spread on the convertible notes to be included in the common shares assuming dilution as the average market price of the Company stock for these periods did not exceed the conversion price.